Satellite symposium 1  Sponsored by Takeda
Thursday 28 September 17:30~18:00 | Place: Convention Hall B
Chairman: Hak Yeon Bae
Sin Gon Kim Korea University, Korea SS1 The ideal partner for improving at least six pathophysiologic disturbances of T2DM
Satellite symposium 2  Sponsored by Ildong
Thursday 28 September 17:30~18:00 | Place: Convention Hall C
Chairman: Young Sik Choi
Sung Hoon Yu Korea Hanyang University, Korea SS2 Clinically beneficial effects of lorcaserin in patients with T2DM
Breakfast symposium 1  Sponsored by Sanofi Aventis
Friday 29 September 07:30~08:30 | Place: Grand Ballroom A
Chairman: Bong Yun Cha
In-Kyung Jeong Kyung Hee University, Korea BS1 Next generation basal insulin: translating clinical trials into a real-world evidence
Breakfast symposium 2  Sponsored by MSD
Friday 29 September 07:30~08:30 | Place: Grand Ballroom C
Chairman: Jin-Woo Kim
Hye Soon Kim Keimyung University, Korea BS2 The latest scientific evidence for dipeptidyl peptidase-4 inhibitors with a focus on sitagliptin
Luncheon symposium 1  Sponsored by Chongkundang
Friday 29 September 12:30~14:00 | Place: Convention Hall A
Chairman: Ho Young Son
Soo Lim Seoul National University, Korea LS1 Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin and lobeglitazone in drug-naive patients with type 2 diabetes
Luncheon symposium 2  Sponsored by Astellas
Friday 29 September 12:30~14:00 | Place: Convention Hall B
Chairman: Keun Yong Park
Eun Gyoung Hong Hallym University, Korea LS2 The multiple benefits of ipragliflozin beyond glycemic control
Luncheon symposium 3  Sponsored by Boehringer Ingelheim
Friday 29 September 12:30~14:00 | Place: Convention Hall C
Chairman: Hyoung Woo Lee
Yong Ho Lee Yonsei University, Korea LS3 Empagliflozin: how will new evidence inform future clinical care?
Luncheon symposium 4  Sponsored by Handok
Friday 29 September 12:30~14:00 | Place: Emerald Hall A
Chairman: Young-Kil Choi
Sung Hee Choi Seoul National University, Korea LS4 Effects of advanced DPP-4i focused on teneligliptin in patients with renal impairment
Breakfast symposium 3  Sponsored by Novonordisk
Saturday 30 September 07:30~08:30 | Place: Grand Ballroom A
Chairman: Seong Yeon Kim
Hyuk Sang Kwon The Catholic University of Korea, Korea BS3 Insulin degludec/insulin aspart: an innovation-driven combination for diabetes care
Breakfast symposium 4  Sponsored by Yuhan
Saturday 30 September 07:30~08:30 | Place: Grand Ballroom C
Chairman: Min Young Chung
Chang Hee Jung University of Ulsan, Korea BS4 Scientific journey of linagliptin, a DPP-4inhibitor, over 5years
Luncheon symposium 5  Sponsored by JW Pharmaceutical
Saturday 30 September 12:20~13:30 | Place: Convention Hall A
Chairman: Young Seol Kim
Kausik Kumar Ray Imperial College London, UK LS5 Not all statins are the same: some guidance on how to manage high-risk patients
Luncheon symposium 6 Sponsored by Novartis
Saturday 30 September 12:20~13:30 | Place: Convention Hall B
Chairman: Sung Koo Kang
Kyung Mook Choi Korea University, Korea LS6 Diabetes and heart failure: novel data of sacubitril & vildagliptin
Luncheon symposium 7  Sponsored by LG
Saturday 30 September 12:20~13:30 | Place: Convention Hall C
Chairman: Yong Ki Kim
Sang Yong Kim Chosun University, Korea LS7 A novel and simple treatment option for dyslipidemia in T2DM: balance study
Quick Menu
Registration
Abstract
On-line submission
Venue
venue
Top